

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 9.29037547 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 9.12717756 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.67241338 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.67241338 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.26951207 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.26951207 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.95212635 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.33583276 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.33583276 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.33583276 |
| 11 | drug metabolic process (GO:0017144) | 6.30361432 |
| 12 | bile acid biosynthetic process (GO:0006699) | 6.19831310 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.15479846 |
| 14 | oxidative demethylation (GO:0070989) | 6.06050896 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.97154392 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.92661130 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.88780871 |
| 18 | urea cycle (GO:0000050) | 5.75285035 |
| 19 | urea metabolic process (GO:0019627) | 5.75285035 |
| 20 | complement activation, alternative pathway (GO:0006957) | 5.67652672 |
| 21 | opsonization (GO:0008228) | 5.62700398 |
| 22 | ethanol metabolic process (GO:0006067) | 5.57483337 |
| 23 | regulation of protein activation cascade (GO:2000257) | 5.53654689 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.49057215 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 5.42525650 |
| 26 | cysteine metabolic process (GO:0006534) | 5.34899440 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.34642813 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.32820908 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 5.29425591 |
| 30 | protein carboxylation (GO:0018214) | 5.25292883 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.25292883 |
| 32 | bile acid metabolic process (GO:0008206) | 5.21469649 |
| 33 | regulation of complement activation (GO:0030449) | 5.20960483 |
| 34 | S-adenosylmethionine metabolic process (GO:0046500) | 5.20779643 |
| 35 | high-density lipoprotein particle remodeling (GO:0034375) | 5.20407975 |
| 36 | regulation of plasminogen activation (GO:0010755) | 5.08357776 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 5.04883862 |
| 38 | regulation of humoral immune response (GO:0002920) | 5.03823733 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 5.00975602 |
| 40 | negative regulation of protein activation cascade (GO:2000258) | 5.00879484 |
| 41 | acute-phase response (GO:0006953) | 4.98031755 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.94015050 |
| 43 | homocysteine metabolic process (GO:0050667) | 4.90883134 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.80223301 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.76103653 |
| 46 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.75822563 |
| 47 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.75822563 |
| 48 | phenylpropanoid metabolic process (GO:0009698) | 4.74472413 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 4.65285621 |
| 50 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.65022416 |
| 51 | amino-acid betaine metabolic process (GO:0006577) | 4.56005829 |
| 52 | lysine metabolic process (GO:0006553) | 4.55007602 |
| 53 | lysine catabolic process (GO:0006554) | 4.55007602 |
| 54 | bile acid and bile salt transport (GO:0015721) | 4.53238802 |
| 55 | plasma lipoprotein particle remodeling (GO:0034369) | 4.51695772 |
| 56 | protein-lipid complex remodeling (GO:0034368) | 4.51695772 |
| 57 | macromolecular complex remodeling (GO:0034367) | 4.51695772 |
| 58 | reverse cholesterol transport (GO:0043691) | 4.49583041 |
| 59 | negative regulation of blood coagulation (GO:0030195) | 4.48411945 |
| 60 | negative regulation of hemostasis (GO:1900047) | 4.48411945 |
| 61 | coenzyme catabolic process (GO:0009109) | 4.47576316 |
| 62 | acylglycerol homeostasis (GO:0055090) | 4.47506228 |
| 63 | triglyceride homeostasis (GO:0070328) | 4.47506228 |
| 64 | indolalkylamine metabolic process (GO:0006586) | 4.44072867 |
| 65 | alkaloid metabolic process (GO:0009820) | 4.43606143 |
| 66 | regulation of cholesterol esterification (GO:0010872) | 4.43386612 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 4.41557819 |
| 68 | amine catabolic process (GO:0009310) | 4.41557819 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 4.39384217 |
| 70 | glycine metabolic process (GO:0006544) | 4.38001871 |
| 71 | cellular glucuronidation (GO:0052695) | 4.33283055 |
| 72 | negative regulation of cholesterol transport (GO:0032375) | 4.29141001 |
| 73 | negative regulation of sterol transport (GO:0032372) | 4.29141001 |
| 74 | cellular amino acid catabolic process (GO:0009063) | 4.25447403 |
| 75 | phospholipid efflux (GO:0033700) | 4.23007845 |
| 76 | cellular ketone body metabolic process (GO:0046950) | 4.22674763 |
| 77 | plasma lipoprotein particle clearance (GO:0034381) | 4.19867439 |
| 78 | ethanol oxidation (GO:0006069) | 4.18822768 |
| 79 | cell wall macromolecule catabolic process (GO:0016998) | 4.13903055 |
| 80 | cell wall macromolecule metabolic process (GO:0044036) | 4.13903055 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 4.12071804 |
| 82 | glutamate metabolic process (GO:0006536) | 4.11981450 |
| 83 | benzene-containing compound metabolic process (GO:0042537) | 4.09961826 |
| 84 | negative regulation of wound healing (GO:0061045) | 4.09157242 |
| 85 | negative regulation of coagulation (GO:0050819) | 4.08461114 |
| 86 | aldehyde catabolic process (GO:0046185) | 4.05757098 |
| 87 | negative regulation of complement activation (GO:0045916) | 4.03620450 |
| 88 | cytolysis (GO:0019835) | 4.02141672 |
| 89 | cellular modified amino acid catabolic process (GO:0042219) | 4.00827303 |
| 90 | flavonoid metabolic process (GO:0009812) | 4.00249645 |
| 91 | arginine metabolic process (GO:0006525) | 3.96756164 |
| 92 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.95681935 |
| 93 | glucuronate metabolic process (GO:0019585) | 3.95492378 |
| 94 | uronic acid metabolic process (GO:0006063) | 3.95492378 |
| 95 | fibrinolysis (GO:0042730) | 3.94940514 |
| 96 | cholesterol efflux (GO:0033344) | 3.93361316 |
| 97 | blood coagulation, intrinsic pathway (GO:0007597) | 3.91480684 |
| 98 | complement activation, classical pathway (GO:0006958) | 3.90389305 |
| 99 | serine family amino acid biosynthetic process (GO:0009070) | 3.88897382 |
| 100 | low-density lipoprotein particle remodeling (GO:0034374) | 3.88883142 |
| 101 | positive regulation of hemostasis (GO:1900048) | 3.88764987 |
| 102 | positive regulation of blood coagulation (GO:0030194) | 3.88764987 |
| 103 | drug catabolic process (GO:0042737) | 3.88535675 |
| 104 | complement activation (GO:0006956) | 3.84399560 |
| 105 | cofactor catabolic process (GO:0051187) | 3.80891753 |
| 106 | protein activation cascade (GO:0072376) | 3.80291589 |
| 107 | acetyl-CoA metabolic process (GO:0006084) | 3.76733323 |
| 108 | organic acid catabolic process (GO:0016054) | 3.73296294 |
| 109 | carboxylic acid catabolic process (GO:0046395) | 3.73296294 |
| 110 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71653049 |
| 111 | acute inflammatory response (GO:0002526) | 3.70483715 |
| 112 | plasma lipoprotein particle assembly (GO:0034377) | 3.70254416 |
| 113 | negative regulation of lipase activity (GO:0060192) | 3.68705617 |
| 114 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.66439084 |
| 115 | positive regulation of lipid catabolic process (GO:0050996) | 3.65596231 |
| 116 | ketone body metabolic process (GO:1902224) | 3.64907679 |
| 117 | regulation of acute inflammatory response (GO:0002673) | 3.64079583 |
| 118 | short-chain fatty acid metabolic process (GO:0046459) | 3.63758451 |
| 119 | hormone catabolic process (GO:0042447) | 3.63348332 |
| 120 | cholesterol homeostasis (GO:0042632) | 3.62101769 |
| 121 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.62068200 |
| 122 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.62068200 |
| 123 | phospholipid homeostasis (GO:0055091) | 3.61378485 |
| 124 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.60166709 |
| 125 | positive regulation of coagulation (GO:0050820) | 3.57251666 |
| 126 | exogenous drug catabolic process (GO:0042738) | 3.56458729 |
| 127 | sterol homeostasis (GO:0055092) | 3.56286072 |
| 128 | aspartate family amino acid catabolic process (GO:0009068) | 3.54965917 |
| 129 | NAD biosynthetic process (GO:0009435) | 3.53609986 |
| 130 | response to mercury ion (GO:0046689) | 3.53501534 |
| 131 | xenobiotic metabolic process (GO:0006805) | 3.45261407 |
| 132 | regulation of apoptotic cell clearance (GO:2000425) | 3.44961925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.77724262 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.08688289 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.60716394 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.19929561 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.00643536 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.46474600 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.88968272 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.63834116 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.58464956 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.01505707 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.0896578 |
| 12 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.94051371 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.90843521 |
| 14 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.71949727 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.60204888 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54353031 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.53517586 |
| 18 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51594646 |
| 19 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.47211806 |
| 20 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.39436159 |
| 21 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28777277 |
| 22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22095420 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.16133764 |
| 24 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11951408 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.11227537 |
| 26 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.09120761 |
| 27 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04300627 |
| 28 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.03365802 |
| 29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.01210408 |
| 30 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.00935701 |
| 31 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.99617041 |
| 32 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.99004016 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98181060 |
| 34 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97174260 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 0.96115629 |
| 36 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.95576486 |
| 37 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.94019254 |
| 38 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.93704602 |
| 39 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.92848181 |
| 40 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92752420 |
| 41 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.91592486 |
| 42 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.90345276 |
| 43 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.89518793 |
| 44 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.89388869 |
| 45 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.88760699 |
| 46 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.85627357 |
| 47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84350347 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.84154119 |
| 49 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.83254499 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83125857 |
| 51 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.83062991 |
| 52 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.82283520 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81275522 |
| 54 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.80500963 |
| 55 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.80305799 |
| 56 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.80265719 |
| 57 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.80135297 |
| 58 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.78331858 |
| 59 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.77576420 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76919001 |
| 61 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.76848966 |
| 62 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.76827515 |
| 63 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.75682958 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.75166368 |
| 65 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.74575904 |
| 66 | KDM2B_26808549_Chip-Seq_REH_Human | 0.74083742 |
| 67 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.73298894 |
| 68 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.73081785 |
| 69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.72641318 |
| 70 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.72563879 |
| 71 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.71239274 |
| 72 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.70622228 |
| 73 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.70343250 |
| 74 | CBP_21632823_ChIP-Seq_H3396_Human | 0.70342831 |
| 75 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69570479 |
| 76 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69555938 |
| 77 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.69515442 |
| 78 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.69445601 |
| 79 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.69351120 |
| 80 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.68787869 |
| 81 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.68756402 |
| 82 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.68617328 |
| 83 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.67380601 |
| 84 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.67117944 |
| 85 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.67051067 |
| 86 | * NFYB_21822215_ChIP-Seq_K562_Human | 0.67033063 |
| 87 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.66569766 |
| 88 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.66384414 |
| 89 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.66206221 |
| 90 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.65951606 |
| 91 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.65852901 |
| 92 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.65520239 |
| 93 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.64667108 |
| 94 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.64534568 |
| 95 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.64503319 |
| 96 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.64503319 |
| 97 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.64198400 |
| 98 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.63643309 |
| 99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63608931 |
| 100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63608931 |
| 101 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.63044995 |
| 102 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.62855713 |
| 103 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.62777792 |
| 104 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62718281 |
| 105 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.62349666 |
| 106 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.62341616 |
| 107 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.62247217 |
| 108 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62123925 |
| 109 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.60804951 |
| 110 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.60754054 |
| 111 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.60628131 |
| 112 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.59980203 |
| 113 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.59712408 |
| 114 | AR_20517297_ChIP-Seq_VCAP_Human | 0.59532768 |
| 115 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.59371190 |
| 116 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.59181785 |
| 117 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.59118383 |
| 118 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.59043666 |
| 119 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58892795 |
| 120 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.58542307 |
| 121 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.58239645 |
| 122 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.57984183 |
| 123 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.57383331 |
| 124 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57070350 |
| 125 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.56700570 |
| 126 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.56197524 |
| 127 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.55776264 |
| 128 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.55298155 |
| 129 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.55298155 |
| 130 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.55100781 |
| 131 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.55007122 |
| 132 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.54562060 |
| 133 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.53884776 |
| 134 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.53636881 |
| 135 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.53325252 |
| 136 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.52988030 |
| 137 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.52836637 |
| 138 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.52689971 |
| 139 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.52482604 |
| 140 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51970073 |
| 141 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.51781657 |
| 142 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.50954511 |
| 143 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.49749837 |
| 144 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.49592995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.37426569 |
| 2 | MP0005360_urolithiasis | 7.67678947 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.59700398 |
| 4 | MP0005365_abnormal_bile_salt | 6.32170569 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.21255858 |
| 6 | MP0003252_abnormal_bile_duct | 4.08690827 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.06075341 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.49471470 |
| 9 | MP0005083_abnormal_biliary_tract | 2.96477696 |
| 10 | MP0009840_abnormal_foam_cell | 2.80793793 |
| 11 | MP0003195_calcinosis | 2.76288967 |
| 12 | MP0005332_abnormal_amino_acid | 2.70414611 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.49386731 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.22658528 |
| 15 | MP0000609_abnormal_liver_physiology | 2.13392648 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.10802092 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 1.98138418 |
| 18 | MP0003868_abnormal_feces_composition | 1.94589441 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 1.86607146 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.85418957 |
| 21 | MP0001764_abnormal_homeostasis | 1.69132571 |
| 22 | MP0009697_abnormal_copulation | 1.65502871 |
| 23 | MP0005451_abnormal_body_composition | 1.55964579 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53329168 |
| 25 | MP0003011_delayed_dark_adaptation | 1.51582343 |
| 26 | MP0005410_abnormal_fertilization | 1.30970002 |
| 27 | MP0005647_abnormal_sex_gland | 1.22925522 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.16719571 |
| 29 | MP0003186_abnormal_redox_activity | 1.15814986 |
| 30 | MP0000598_abnormal_liver_morphology | 1.14608236 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.09319380 |
| 32 | MP0005670_abnormal_white_adipose | 1.07556121 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.07310809 |
| 34 | MP0009764_decreased_sensitivity_to | 0.99124284 |
| 35 | MP0002282_abnormal_trachea_morphology | 0.98806020 |
| 36 | MP0000604_amyloidosis | 0.98788466 |
| 37 | MP0009763_increased_sensitivity_to | 0.96536083 |
| 38 | MP0002254_reproductive_system_inflammat | 0.95776078 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.92363438 |
| 40 | MP0010368_abnormal_lymphatic_system | 0.88776945 |
| 41 | MP0008469_abnormal_protein_level | 0.85899667 |
| 42 | MP0009642_abnormal_blood_homeostasis | 0.84879603 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 0.83582364 |
| 44 | MP0005535_abnormal_body_temperature | 0.82981776 |
| 45 | MP0002971_abnormal_brown_adipose | 0.82553523 |
| 46 | MP0002876_abnormal_thyroid_physiology | 0.80034531 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 0.79506813 |
| 48 | MP0005187_abnormal_penis_morphology | 0.79065114 |
| 49 | MP0001661_extended_life_span | 0.77433609 |
| 50 | MP0009785_altered_susceptibility_to | 0.77045397 |
| 51 | MP0002078_abnormal_glucose_homeostasis | 0.76669181 |
| 52 | MP0005376_homeostasis/metabolism_phenot | 0.75706164 |
| 53 | MP0001915_intracranial_hemorrhage | 0.74901287 |
| 54 | MP0004130_abnormal_muscle_cell | 0.73107452 |
| 55 | MP0004381_abnormal_hair_follicle | 0.72969906 |
| 56 | MP0009765_abnormal_xenobiotic_induced | 0.71150579 |
| 57 | MP0005408_hypopigmentation | 0.70199639 |
| 58 | MP0005334_abnormal_fat_pad | 0.69885668 |
| 59 | MP0005220_abnormal_exocrine_pancreas | 0.66903011 |
| 60 | MP0003879_abnormal_hair_cell | 0.64535459 |
| 61 | MP0002928_abnormal_bile_duct | 0.63048798 |
| 62 | MP0002249_abnormal_larynx_morphology | 0.61093785 |
| 63 | MP0003690_abnormal_glial_cell | 0.60593297 |
| 64 | MP0006035_abnormal_mitochondrial_morpho | 0.60137946 |
| 65 | MP0005266_abnormal_metabolism | 0.59330210 |
| 66 | MP0002332_abnormal_exercise_endurance | 0.58590773 |
| 67 | MP0001756_abnormal_urination | 0.55942599 |
| 68 | MP0003329_amyloid_beta_deposits | 0.54936536 |
| 69 | MP0000639_abnormal_adrenal_gland | 0.53060200 |
| 70 | MP0005448_abnormal_energy_balance | 0.52955664 |
| 71 | MP0008872_abnormal_physiological_respon | 0.49658637 |
| 72 | MP0003724_increased_susceptibility_to | 0.48110322 |
| 73 | MP0000579_abnormal_nail_morphology | 0.47422644 |
| 74 | MP0003718_maternal_effect | 0.47167042 |
| 75 | MP0002837_dystrophic_cardiac_calcinosis | 0.46214475 |
| 76 | MP0008874_decreased_physiological_sensi | 0.45768180 |
| 77 | MP0002822_catalepsy | 0.44160048 |
| 78 | MP0005023_abnormal_wound_healing | 0.43665405 |
| 79 | MP0005395_other_phenotype | 0.43562594 |
| 80 | MP0000427_abnormal_hair_cycle | 0.42524941 |
| 81 | MP0008873_increased_physiological_sensi | 0.42229769 |
| 82 | MP0003953_abnormal_hormone_level | 0.41280712 |
| 83 | MP0005166_decreased_susceptibility_to | 0.39603257 |
| 84 | MP0001545_abnormal_hematopoietic_system | 0.39102708 |
| 85 | MP0005397_hematopoietic_system_phenotyp | 0.39102708 |
| 86 | MP0002136_abnormal_kidney_physiology | 0.39067140 |
| 87 | MP0002796_impaired_skin_barrier | 0.38861861 |
| 88 | MP0003638_abnormal_response/metabolism_ | 0.38770668 |
| 89 | MP0005666_abnormal_adipose_tissue | 0.38770037 |
| 90 | MP0009053_abnormal_anal_canal | 0.38680644 |
| 91 | MP0005464_abnormal_platelet_physiology | 0.36928880 |
| 92 | MP0000467_abnormal_esophagus_morphology | 0.36739243 |
| 93 | MP0000230_abnormal_systemic_arterial | 0.35549000 |
| 94 | MP0009115_abnormal_fat_cell | 0.32778841 |
| 95 | MP0003075_altered_response_to | 0.32708222 |
| 96 | MP0003698_abnormal_male_reproductive | 0.32027281 |
| 97 | MP0005164_abnormal_response_to | 0.31621772 |
| 98 | MP0002970_abnormal_white_adipose | 0.31259190 |
| 99 | MP0003436_decreased_susceptibility_to | 0.30790278 |
| 100 | MP0004782_abnormal_surfactant_physiolog | 0.28853555 |
| 101 | MP0004883_abnormal_blood_vessel | 0.28768940 |
| 102 | MP0009672_abnormal_birth_weight | 0.26671411 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.26670698 |
| 104 | MP0009384_cardiac_valve_regurgitation | 0.26563094 |
| 105 | MP0001929_abnormal_gametogenesis | 0.26441154 |
| 106 | MP0005595_abnormal_vascular_smooth | 0.26263512 |
| 107 | MP0002132_abnormal_respiratory_system | 0.25871372 |
| 108 | MP0006292_abnormal_olfactory_placode | 0.25205239 |
| 109 | MP0002060_abnormal_skin_morphology | 0.24899992 |
| 110 | MP0000249_abnormal_blood_vessel | 0.24794497 |
| 111 | MP0001845_abnormal_inflammatory_respons | 0.24364684 |
| 112 | MP0002168_other_aberrant_phenotype | 0.24110773 |
| 113 | MP0002161_abnormal_fertility/fecundity | 0.23539739 |
| 114 | MP0003699_abnormal_female_reproductive | 0.23498683 |
| 115 | MP0001986_abnormal_taste_sensitivity | 0.20961899 |
| 116 | MP0001851_eye_inflammation | 0.18972409 |
| 117 | MP0002234_abnormal_pharynx_morphology | 0.18517181 |
| 118 | MP0002135_abnormal_kidney_morphology | 0.18326722 |
| 119 | MP0010155_abnormal_intestine_physiology | 0.17958758 |
| 120 | MP0005646_abnormal_pituitary_gland | 0.17168991 |
| 121 | MP0003633_abnormal_nervous_system | 0.16679945 |
| 122 | MP0002128_abnormal_blood_circulation | 0.16495220 |
| 123 | MP0001881_abnormal_mammary_gland | 0.15897482 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.59482468 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.34599209 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.29700081 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.71150160 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.70595386 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.34848229 |
| 7 | Xanthomatosis (HP:0000991) | 6.26322270 |
| 8 | Complement deficiency (HP:0004431) | 5.79322028 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.42530750 |
| 10 | Epidermoid cyst (HP:0200040) | 5.05219260 |
| 11 | Joint hemorrhage (HP:0005261) | 4.76809653 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.68409601 |
| 13 | Hyperammonemia (HP:0001987) | 4.44038283 |
| 14 | Hyperglycinemia (HP:0002154) | 4.37273291 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.33766399 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.33068172 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.23578354 |
| 18 | Abnormality of complement system (HP:0005339) | 4.23052886 |
| 19 | Fat malabsorption (HP:0002630) | 4.20993931 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.12186414 |
| 21 | Ketosis (HP:0001946) | 4.11146593 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.10239231 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.10037297 |
| 24 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.05695345 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 4.03707416 |
| 26 | Hyperglycinuria (HP:0003108) | 3.79591576 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 3.79550833 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.77794971 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.77794971 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.67527660 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.61600315 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.60601211 |
| 33 | Spontaneous abortion (HP:0005268) | 3.38161136 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.23668780 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.22437634 |
| 36 | Steatorrhea (HP:0002570) | 3.13398944 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.08076399 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.07719314 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.05523498 |
| 40 | Myocardial infarction (HP:0001658) | 2.94598476 |
| 41 | Skin nodule (HP:0200036) | 2.92467307 |
| 42 | Delayed CNS myelination (HP:0002188) | 2.90694322 |
| 43 | Ketoacidosis (HP:0001993) | 2.88016674 |
| 44 | Neonatal hypoglycemia (HP:0001998) | 2.86805905 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.83842033 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.83135600 |
| 47 | Acanthocytosis (HP:0001927) | 2.81695371 |
| 48 | Hypochromic microcytic anemia (HP:0004840) | 2.74149500 |
| 49 | Vascular calcification (HP:0004934) | 2.70820748 |
| 50 | Fair hair (HP:0002286) | 2.70043781 |
| 51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.62145765 |
| 52 | Metabolic acidosis (HP:0001942) | 2.59669345 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 2.59266926 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.49050042 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.49050042 |
| 56 | Lethargy (HP:0001254) | 2.47538284 |
| 57 | Glomerulonephritis (HP:0000099) | 2.45521879 |
| 58 | Cerebral edema (HP:0002181) | 2.44665336 |
| 59 | Gout (HP:0001997) | 2.43757676 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 2.40579439 |
| 61 | Cardiovascular calcification (HP:0011915) | 2.40468588 |
| 62 | Purpura (HP:0000979) | 2.40362105 |
| 63 | Abnormal gallbladder physiology (HP:0012438) | 2.36928879 |
| 64 | Cholecystitis (HP:0001082) | 2.36928879 |
| 65 | Hypoglycemic seizures (HP:0002173) | 2.35492961 |
| 66 | Neonatal onset (HP:0003623) | 2.35404092 |
| 67 | Spastic diplegia (HP:0001264) | 2.35056248 |
| 68 | Pulmonary embolism (HP:0002204) | 2.33043659 |
| 69 | Cholelithiasis (HP:0001081) | 2.31773844 |
| 70 | Osteomalacia (HP:0002749) | 2.29785265 |
| 71 | Mitral stenosis (HP:0001718) | 2.29592027 |
| 72 | Irritability (HP:0000737) | 2.25268903 |
| 73 | Esophageal varix (HP:0002040) | 2.23341611 |
| 74 | Enlarged kidneys (HP:0000105) | 2.23320587 |
| 75 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.20834759 |
| 76 | Joint swelling (HP:0001386) | 2.13858365 |
| 77 | Renal cortical cysts (HP:0000803) | 2.12253300 |
| 78 | Brushfield spots (HP:0001088) | 2.12049218 |
| 79 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.11795802 |
| 80 | Amyloidosis (HP:0011034) | 2.10051933 |
| 81 | Menorrhagia (HP:0000132) | 2.08465380 |
| 82 | Pancreatitis (HP:0001733) | 2.07646116 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 2.04784600 |
| 84 | Poikilocytosis (HP:0004447) | 2.03329647 |
| 85 | Gingival bleeding (HP:0000225) | 2.02283921 |
| 86 | Sensorimotor neuropathy (HP:0007141) | 2.01875999 |
| 87 | Thrombophlebitis (HP:0004418) | 2.00980167 |
| 88 | Malnutrition (HP:0004395) | 2.00329120 |
| 89 | Abnormality of the gallbladder (HP:0005264) | 2.00273620 |
| 90 | Increased serum ferritin (HP:0003281) | 1.99495813 |
| 91 | Rickets (HP:0002748) | 1.94693079 |
| 92 | Late onset (HP:0003584) | 1.94407829 |
| 93 | Generalized hypopigmentation of hair (HP:0011358) | 1.92912129 |
| 94 | Gangrene (HP:0100758) | 1.91054524 |
| 95 | Vomiting (HP:0002013) | 1.90638239 |
| 96 | Hypophosphatemic rickets (HP:0004912) | 1.89795567 |
| 97 | Reduced antithrombin III activity (HP:0001976) | 1.89328868 |
| 98 | Cerebral palsy (HP:0100021) | 1.87976664 |
| 99 | Hemorrhage of the eye (HP:0011885) | 1.87900668 |
| 100 | Arthropathy (HP:0003040) | 1.85666131 |
| 101 | Opisthotonus (HP:0002179) | 1.85047628 |
| 102 | Elevated alkaline phosphatase (HP:0003155) | 1.84710433 |
| 103 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81588362 |
| 104 | Elevated hepatic transaminases (HP:0002910) | 1.78588245 |
| 105 | Generalized aminoaciduria (HP:0002909) | 1.78500031 |
| 106 | Epistaxis (HP:0000421) | 1.75429740 |
| 107 | Abnormal cartilage morphology (HP:0002763) | 1.75276783 |
| 108 | Alkalosis (HP:0001948) | 1.75089908 |
| 109 | Abnormality of vitamin metabolism (HP:0100508) | 1.73640987 |
| 110 | Status epilepticus (HP:0002133) | 1.73276507 |
| 111 | Nephritis (HP:0000123) | 1.72791185 |
| 112 | Hyperphosphaturia (HP:0003109) | 1.72789006 |
| 113 | Acute hepatic failure (HP:0006554) | 1.72431756 |
| 114 | Stroke (HP:0001297) | 1.72317082 |
| 115 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.72064637 |
| 116 | Proximal tubulopathy (HP:0000114) | 1.71037623 |
| 117 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.69514499 |
| 118 | Blue irides (HP:0000635) | 1.69059782 |
| 119 | Abnormality of proline metabolism (HP:0010907) | 1.63978381 |
| 120 | Hydroxyprolinuria (HP:0003080) | 1.63978381 |
| 121 | Abnormality of urine glucose concentration (HP:0011016) | 1.59665977 |
| 122 | Glycosuria (HP:0003076) | 1.59665977 |
| 123 | Atrioventricular block (HP:0001678) | 1.58020281 |
| 124 | Increased mean platelet volume (HP:0011877) | 1.55720939 |
| 125 | Abnormality of the Achilles tendon (HP:0005109) | 1.55594612 |
| 126 | Abnormal delivery (HP:0001787) | 1.54346296 |
| 127 | Abnormal biliary tract physiology (HP:0012439) | 1.51828007 |
| 128 | Bile duct proliferation (HP:0001408) | 1.51828007 |
| 129 | Bifid scrotum (HP:0000048) | 1.46517468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.62989532 |
| 2 | SIK1 | 4.25082644 |
| 3 | FGFR4 | 3.99442402 |
| 4 | ERN1 | 3.82061018 |
| 5 | INSRR | 3.53844375 |
| 6 | ERBB4 | 3.26279217 |
| 7 | TAOK3 | 2.75832312 |
| 8 | PDK4 | 2.61237080 |
| 9 | PDK3 | 2.61237080 |
| 10 | MAP2K4 | 2.54451098 |
| 11 | MST1R | 2.33889084 |
| 12 | PIK3CA | 2.19536263 |
| 13 | PIK3CG | 2.04874912 |
| 14 | NTRK3 | 1.83034949 |
| 15 | LATS1 | 1.82583873 |
| 16 | FRK | 1.77092536 |
| 17 | MAPK11 | 1.75370276 |
| 18 | TNK2 | 1.70688093 |
| 19 | FLT3 | 1.61293387 |
| 20 | PKN2 | 1.53641420 |
| 21 | ABL2 | 1.53199794 |
| 22 | PDK2 | 1.51131504 |
| 23 | FGFR2 | 1.48712695 |
| 24 | EIF2AK3 | 1.37649233 |
| 25 | RIPK1 | 1.36927428 |
| 26 | STK38L | 1.26213940 |
| 27 | DAPK2 | 1.22824164 |
| 28 | PTK6 | 1.18987214 |
| 29 | STK16 | 1.15717577 |
| 30 | KDR | 1.14189334 |
| 31 | PRKAA2 | 1.13789633 |
| 32 | BCR | 1.11865487 |
| 33 | PKN1 | 1.11281946 |
| 34 | PRKG1 | 1.10162606 |
| 35 | TYK2 | 1.09754622 |
| 36 | IRAK1 | 1.06721082 |
| 37 | MAPK15 | 1.03625250 |
| 38 | MAPK4 | 0.97587171 |
| 39 | MAP3K7 | 0.96882433 |
| 40 | JAK2 | 0.96328004 |
| 41 | MAP4K2 | 0.94934053 |
| 42 | PRKCZ | 0.93103813 |
| 43 | PINK1 | 0.91919305 |
| 44 | BMPR1B | 0.91738140 |
| 45 | NEK9 | 0.91508389 |
| 46 | WNK3 | 0.90833744 |
| 47 | GRK6 | 0.90197357 |
| 48 | ERBB2 | 0.90026947 |
| 49 | MAP3K14 | 0.89024517 |
| 50 | EPHB1 | 0.87971471 |
| 51 | CAMK1D | 0.86492702 |
| 52 | ADRBK2 | 0.86375633 |
| 53 | BRSK2 | 0.86246632 |
| 54 | CSK | 0.86221506 |
| 55 | JAK1 | 0.80612308 |
| 56 | BLK | 0.79889879 |
| 57 | CDK6 | 0.79248769 |
| 58 | PRKACG | 0.78034411 |
| 59 | CAMK2G | 0.75824637 |
| 60 | CAMKK2 | 0.74283608 |
| 61 | IRAK2 | 0.74151404 |
| 62 | MET | 0.71254895 |
| 63 | TRIB3 | 0.69798840 |
| 64 | TBK1 | 0.69202006 |
| 65 | AKT3 | 0.67936815 |
| 66 | MAPK12 | 0.67410749 |
| 67 | MAP3K11 | 0.67223906 |
| 68 | PRKCQ | 0.67160116 |
| 69 | MAP3K10 | 0.66162843 |
| 70 | PRKAA1 | 0.65022304 |
| 71 | EPHA4 | 0.64703295 |
| 72 | GSK3A | 0.63927680 |
| 73 | CSNK1D | 0.62920576 |
| 74 | PRKACB | 0.62346305 |
| 75 | MAP2K6 | 0.62278544 |
| 76 | PTK2B | 0.60734492 |
| 77 | ICK | 0.59679797 |
| 78 | GRK1 | 0.59229123 |
| 79 | PRKCB | 0.58281603 |
| 80 | GRK7 | 0.57579141 |
| 81 | DYRK1A | 0.56508167 |
| 82 | CSNK1E | 0.56438000 |
| 83 | TEC | 0.55985114 |
| 84 | IRAK3 | 0.55003718 |
| 85 | PDK1 | 0.54780766 |
| 86 | PRKCG | 0.54535017 |
| 87 | PRKCE | 0.54088522 |
| 88 | PDPK1 | 0.53813624 |
| 89 | MAP3K3 | 0.53700999 |
| 90 | MAP3K2 | 0.53548813 |
| 91 | IKBKE | 0.52865061 |
| 92 | IKBKB | 0.52783465 |
| 93 | TIE1 | 0.52758127 |
| 94 | CSNK2A1 | 0.52515535 |
| 95 | KIT | 0.51992266 |
| 96 | CSF1R | 0.51697324 |
| 97 | CAMK1G | 0.51354726 |
| 98 | RPS6KA3 | 0.50676065 |
| 99 | EGFR | 0.50640798 |
| 100 | PTK2 | 0.49836296 |
| 101 | SGK1 | 0.49097849 |
| 102 | MAP2K3 | 0.48715706 |
| 103 | MAP3K6 | 0.46157709 |
| 104 | MAPK7 | 0.45768411 |
| 105 | CHUK | 0.44921414 |
| 106 | PIM2 | 0.43599563 |
| 107 | MYLK | 0.43262240 |
| 108 | SRC | 0.43169306 |
| 109 | MAP3K13 | 0.43116827 |
| 110 | ACVR1B | 0.42568232 |
| 111 | DYRK1B | 0.42395243 |
| 112 | PBK | 0.42377571 |
| 113 | EPHA3 | 0.41153211 |
| 114 | IGF1R | 0.40375436 |
| 115 | MAP2K1 | 0.39291143 |
| 116 | MAP3K5 | 0.39216300 |
| 117 | CSNK1A1 | 0.38511675 |
| 118 | NLK | 0.37603856 |
| 119 | PRPF4B | 0.37162853 |
| 120 | TGFBR2 | 0.37157705 |
| 121 | EIF2AK2 | 0.36801948 |
| 122 | CSNK1G1 | 0.36590635 |
| 123 | CDK4 | 0.33951804 |
| 124 | MAP2K2 | 0.33344632 |
| 125 | ARAF | 0.33293260 |
| 126 | CSNK2A2 | 0.32401823 |
| 127 | MAPK3 | 0.32141269 |
| 128 | STK3 | 0.32072500 |
| 129 | ERBB3 | 0.31590913 |
| 130 | PRKCA | 0.31402881 |
| 131 | FER | 0.31054860 |
| 132 | AKT2 | 0.31021862 |
| 133 | SGK3 | 0.29672796 |
| 134 | LMTK2 | 0.29198291 |
| 135 | STK38 | 0.28986085 |
| 136 | CDK12 | 0.26955133 |
| 137 | ABL1 | 0.24905811 |
| 138 | CSNK1G2 | 0.24149535 |
| 139 | FGFR3 | 0.22172808 |
| 140 | PRKACA | 0.22139796 |
| 141 | CAMK2A | 0.21123945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 5.04585529 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.70538753 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.55607915 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.46159341 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.29950890 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.01292203 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.79493939 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69983500 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.59739449 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.53223100 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49403260 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46380236 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.30269713 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28395321 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16718496 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.08883584 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.08234167 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08060249 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.97827985 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96385193 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.95193222 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92289967 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90573855 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.83802559 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76866094 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73691339 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73514106 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.72525788 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72512867 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72454784 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71575076 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.70044437 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.63944502 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.49873150 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46481048 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46134328 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43035020 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.35724781 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34656882 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33852803 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31714472 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.28986846 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26678147 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.26070611 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23165881 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23006960 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16296329 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09502575 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08678304 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.08028791 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07677125 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96283568 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92888904 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88405121 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87666630 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87600035 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86538506 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84184217 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.82546422 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82284754 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81952380 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81259341 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78744373 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68284132 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66771566 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.64535837 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49929450 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.44623667 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.40123539 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36741737 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32894143 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31919994 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29300094 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20635004 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20494300 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18683848 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18415060 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.17283191 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.15944438 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09848783 |
| 81 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.04173301 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00654756 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2700834 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | -0.2691517 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2672766 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | -0.2533442 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2505696 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2455584 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | -0.2415812 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2138809 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2123011 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.2122510 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1978579 |
| 94 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1886634 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1883208 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1859457 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1754484 |
| 98 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1692265 |
| 99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1636600 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1528109 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1459929 |
| 102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1100275 |
| 103 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1068002 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0793769 |
| 105 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0632131 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0570376 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0307241 |
| 108 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0140882 |

